Cargando…

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART

Cytomegalovirus (CMV) infection is common among HIV-infected patients but its repercussion on the course of CD4+ and CD8+ T cells after cART initiation remains elusive. The French Dat'AIDS cohort enrolled 5,688 patients on first-line cART, from which we selected patients who achieved HIV suppre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poizot-Martin, Isabelle, Allavena, Clotilde, Duvivier, Claudine, Cano, Carla Eliana, Guillouet de Salvador, Francine, Rey, David, Dellamonica, Pierre, Cuzin, Lise, Cheret, Antoine, Hoen, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100980/ https://www.ncbi.nlm.nih.gov/pubmed/27824907 http://dx.doi.org/10.1371/journal.pone.0165774

Ejemplares similares

First-line cART regimen impacts the course of CD8(+) T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study
por: Cotte, Laurent, et al.
Publicado: (2017)

Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort
por: Allavena, Clotilde, et al.
Publicado: (2014)

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

Combined Analysis of Early CD4(+) T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation
por: Leserer, Saskia, et al.
Publicado: (2021)

RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines
por: Chang, W. L. William, et al.
Publicado: (2020)

CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients
por: Jaskula, Emilia, et al.
Publicado: (2012)

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach
por: Cuzin, Lise, et al.
Publicado: (2015)

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
por: Virlogeux, Victor, et al.
Publicado: (2017)

CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
por: Costagliola, Dominique, et al.
Publicado: (2014)

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study
por: Cuzin, Lise, et al.
Publicado: (2017)

Raltegravir Inclusion Decreases CD4 T-Cells Intra-Cellular Viral Load and Increases CD4 and CD28 Positive T-Cells in Selected HIV Patients
por: Kumar, Gaurav, et al.
Publicado: (2022)

Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients
por: Hughes, David, et al.
Publicado: (2008)

Economic impact of generic antiretrovirals in France for HIV patients’ care: a simulation between 2019 and 2023
por: Demeulemeester, Romain, et al.
Publicado: (2022)

Tolerance and durability of abacavir/lamivudine (ABC/3TC)-containing regimens: results from a large prospective French cohort
por: Cuzin, L, et al.
Publicado: (2010)

How Do Donor-Recipient CMV Serostatus and Post-Hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
por: Vaezi, Mohammad, et al.
Publicado: (2017)

Pneumocystis jirovecii Pneumonia and Toxoplasmosis in PWH With HIV-Controlled Disease Treated for Solid Malignancies: A DAT’AIDS Study
por: Pansu, Nathalie, et al.
Publicado: (2022)

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
por: Gantner, Pierre, et al.
Publicado: (2019)

CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation
por: Calderin Sollet, Zuleika, et al.
Publicado: (2023)

CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART
por: Sauter, Rafael, et al.
Publicado: (2016)

A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection
por: Bacchus, Charline, et al.
Publicado: (2013)

HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat’AIDS cohort
por: Hentzien, Maxime, et al.
Publicado: (2019)

Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors
por: Pita-Lopez, María Luisa, et al.
Publicado: (2009)

The hallmarks of CMV-specific CD8 T-cell differentiation
por: van den Berg, Sara P. H., et al.
Publicado: (2019)

91. Differential Impact of Cytomegalovirus (CMV) Donor (D) Serostatus on Rates and Kinetics of CMV Viremia among CMV Seropositive Recipients (R+) of Ex vivo T-cell Depleted (TCD) and Unmodified (CONV) Hematopoietic Cell Transplants (HCT)
por: Stern, Anat, et al.
Publicado: (2019)

A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART
por: Gondois-Rey, Françoise, et al.
Publicado: (2017)

Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France
por: Rojas Rojas, Teresa, et al.
Publicado: (2022)

Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART
por: Salido, Jimena, et al.
Publicado: (2021)

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score
por: Hentzien, Maxime, et al.
Publicado: (2018)

Impact of HIV on CD8+ T Cell CD57 Expression Is Distinct from That of CMV and Aging
por: Lee, Sulggi A., et al.
Publicado: (2014)

T-Cell Immunity Panel Measures CMV-Specific CD4 and CD8 T-Cell Responses
por: Lutgen, Cory B, et al.
Publicado: (2017)

Immunophenotyping of Rhesus CMV‐Specific CD8 T‐Cell Populations
por: Pomplun, Nicholas L., et al.
Publicado: (2020)

CMV-independent increase in CD27−CD28+ CD8+ EMRA T cells is inversely related to mortality in octogenarians
por: Martin-Ruiz, Carmen, et al.
Publicado: (2020)

Noninvasive Determination of CMV Serostatus From Dried Buccal Swab Samples: Assay Development, Validation, and Application to 1.2 Million Samples
por: Behrens, Geoffrey A, et al.
Publicado: (2020)

Mass Cytometry Analysis Reveals the Landscape and Dynamics of CD32a(+) CD4(+) T Cells From Early HIV Infection to Effective cART
por: Coindre, Sixtine, et al.
Publicado: (2018)

CD4/CD8 Ratio as a Predictor for the Occurrence of Metabolic Syndrome in HIV / AIDS Patients During 6 Months of cART Therapy
por: Gojak, Refet, et al.
Publicado: (2019)

CD56(dim) NK Cell is an Important Factor in T Cell Depletion of cART-Treated AIDS Patients
por: Qian, Feng, et al.
Publicado: (2022)

Impact of early cART on HIV blood and semen compartments at the time of primary infection
por: Chéret, Antoine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ksl7lo0ogfgjgdsr5kp5blo3oe